Cargando…
Mechanisms of Chemotherapy-Induced Neurotoxicity
Since the first clinical trials conducted after World War II, chemotherapeutic drugs have been extensively used in the clinic as the main cancer treatment either alone or as an adjuvant therapy before and after surgery. Although the use of chemotherapeutic drugs improved the survival of cancer patie...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996259/ https://www.ncbi.nlm.nih.gov/pubmed/35418856 http://dx.doi.org/10.3389/fphar.2022.750507 |
_version_ | 1784684457976922112 |
---|---|
author | Was, Halina Borkowska, Agata Bagues, Ana Tu, Longlong Liu, Julia Y. H. Lu, Zengbing Rudd, John A. Nurgali, Kulmira Abalo, Raquel |
author_facet | Was, Halina Borkowska, Agata Bagues, Ana Tu, Longlong Liu, Julia Y. H. Lu, Zengbing Rudd, John A. Nurgali, Kulmira Abalo, Raquel |
author_sort | Was, Halina |
collection | PubMed |
description | Since the first clinical trials conducted after World War II, chemotherapeutic drugs have been extensively used in the clinic as the main cancer treatment either alone or as an adjuvant therapy before and after surgery. Although the use of chemotherapeutic drugs improved the survival of cancer patients, these drugs are notorious for causing many severe side effects that significantly reduce the efficacy of anti-cancer treatment and patients’ quality of life. Many widely used chemotherapy drugs including platinum-based agents, taxanes, vinca alkaloids, proteasome inhibitors, and thalidomide analogs may cause direct and indirect neurotoxicity. In this review we discuss the main effects of chemotherapy on the peripheral and central nervous systems, including neuropathic pain, chemobrain, enteric neuropathy, as well as nausea and emesis. Understanding mechanisms involved in chemotherapy-induced neurotoxicity is crucial for the development of drugs that can protect the nervous system, reduce symptoms experienced by millions of patients, and improve the outcome of the treatment and patients’ quality of life. |
format | Online Article Text |
id | pubmed-8996259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89962592022-04-12 Mechanisms of Chemotherapy-Induced Neurotoxicity Was, Halina Borkowska, Agata Bagues, Ana Tu, Longlong Liu, Julia Y. H. Lu, Zengbing Rudd, John A. Nurgali, Kulmira Abalo, Raquel Front Pharmacol Pharmacology Since the first clinical trials conducted after World War II, chemotherapeutic drugs have been extensively used in the clinic as the main cancer treatment either alone or as an adjuvant therapy before and after surgery. Although the use of chemotherapeutic drugs improved the survival of cancer patients, these drugs are notorious for causing many severe side effects that significantly reduce the efficacy of anti-cancer treatment and patients’ quality of life. Many widely used chemotherapy drugs including platinum-based agents, taxanes, vinca alkaloids, proteasome inhibitors, and thalidomide analogs may cause direct and indirect neurotoxicity. In this review we discuss the main effects of chemotherapy on the peripheral and central nervous systems, including neuropathic pain, chemobrain, enteric neuropathy, as well as nausea and emesis. Understanding mechanisms involved in chemotherapy-induced neurotoxicity is crucial for the development of drugs that can protect the nervous system, reduce symptoms experienced by millions of patients, and improve the outcome of the treatment and patients’ quality of life. Frontiers Media S.A. 2022-03-28 /pmc/articles/PMC8996259/ /pubmed/35418856 http://dx.doi.org/10.3389/fphar.2022.750507 Text en Copyright © 2022 Was, Borkowska, Bagues, Tu, Liu, Lu, Rudd, Nurgali and Abalo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Was, Halina Borkowska, Agata Bagues, Ana Tu, Longlong Liu, Julia Y. H. Lu, Zengbing Rudd, John A. Nurgali, Kulmira Abalo, Raquel Mechanisms of Chemotherapy-Induced Neurotoxicity |
title | Mechanisms of Chemotherapy-Induced Neurotoxicity |
title_full | Mechanisms of Chemotherapy-Induced Neurotoxicity |
title_fullStr | Mechanisms of Chemotherapy-Induced Neurotoxicity |
title_full_unstemmed | Mechanisms of Chemotherapy-Induced Neurotoxicity |
title_short | Mechanisms of Chemotherapy-Induced Neurotoxicity |
title_sort | mechanisms of chemotherapy-induced neurotoxicity |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996259/ https://www.ncbi.nlm.nih.gov/pubmed/35418856 http://dx.doi.org/10.3389/fphar.2022.750507 |
work_keys_str_mv | AT washalina mechanismsofchemotherapyinducedneurotoxicity AT borkowskaagata mechanismsofchemotherapyinducedneurotoxicity AT baguesana mechanismsofchemotherapyinducedneurotoxicity AT tulonglong mechanismsofchemotherapyinducedneurotoxicity AT liujuliayh mechanismsofchemotherapyinducedneurotoxicity AT luzengbing mechanismsofchemotherapyinducedneurotoxicity AT ruddjohna mechanismsofchemotherapyinducedneurotoxicity AT nurgalikulmira mechanismsofchemotherapyinducedneurotoxicity AT abaloraquel mechanismsofchemotherapyinducedneurotoxicity |